Stock Price
0.27
Daily Change
-0.01 -1.82%
Monthly
-14.29%
Yearly
14.89%
Q3 Forecast
0.28

Paradigm Biopharmaceuticals reported AUD17.82M in Cash and Equivalent for its fiscal semester ending in June of 2024.


Cash And Equivalent Change Date
Avita Medical AUD 14.05M 3.4M Dec/2024
Medical Developments International AUD 17.62M 7.88M Dec/2024
Neuren Pharmaceuticals AUD 3.15M 582K Dec/2024
Pacific Edge NZD 22.57M 637K Mar/2025
PYC Therapeutics AUD 49.25M 17.62M Dec/2024
Telix Pharmaceuticals AUD 710.35M 587.11M Dec/2024